Keeping You Updated
PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group
Oxford, UK (PRWEB) June 24, 2009 -- PharmaVentures Ltd, announced today that it provided the Helsinn Group with the transaction advisory support for the successful sale of Helsinn Chemicals Ireland Ltd to the Medinco C.F.M. Group, which was announced on Monday. Full details of this transaction can be found here.
Dr Fintan Walton, CEO, PharmaVentures commented, "PharmaVentures are delighted to have supported Helsinn in the strategic divestment of its pharmaceutical API manufacturing business. This success was achieved despite the current difficult economic environment and demonstrates why we are recognised as leaders in deal making. It also helps ensure an ongoing future for the Helsinn Chemicals Ireland business and its employees under the new ownership of the Medinco C.F.M. Group."
Please contact:
Dr Fintan Walton, CEO PharmaVentures Ltd +44 (0) 1865 784 187
- ends -
Notes to Editors:
PharmaVentures® (http://www.pharmaventures.com) is a leading international corporate advisory firm supporting its clients’ growth ambitions in the health care industry. It comprises two divisions: PharmaVentures Corporate Advisory and PharmaVentures Business Media which produces the highly popular PharmaDeals® range of intelligence products including analysis tools and reports as well as the world's first dedicated online pharmaceutical television channel PharmaTelevision® (http://www.pharmatelevision.com). PharmaTelevision News is a daily ‘must see’ news service broadcast worldwide.
Now in its 12th year, PharmaVentures is based in Oxford, UK, employs over 30 people, many educated to PhD level. It is active worldwide, including the USA and AsiaPacific. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisors, investment companies and governments.
For further information please contact:
Lisa Holloway
Marketing
lisa.holloway@pharmaventures.com